Position in BIIB
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$13,564,462
+$10,301,422 QoQ
Shares Held
62,781
+292.4% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
3.65%
of 13F equity value
Holder Rank
#150
of 1,036 holders
Holding Since
Mar 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atle Fund Management AB holds $117,376,751 across 6 Drug Manufacturers - General names. BIIB ranks #5 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,821 | $35,768,205 | |
| 2 | MRK |
Merck & Co., Inc.
|
189,357 | $24,332,374 | |
| 3 | JNJ |
Johnson & Johnson
|
85,425 | $21,695,387 | |
| 4 | ABBV |
AbbVie Inc.
|
64,325 | $16,186,743 | |
| 5 | BIIB |
Biogen Inc.
This page
|
62,781 | $13,564,462 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
46,142 | $5,829,580 |
All Filings in BIIB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,564,462 | 62,781 | Shares | Sole | 2026-07-24 | |
| 2022-06-30 | $3,263,040 | 16,000 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $5,896,800 | 28,000 | Shares | Sole | 2022-05-05 | |
| No filing history on record for this holder in this stock. | ||||||